Cushman & Wakefield Announces Major Reporting Changes and Recasts Financials for 2024-2025

Key Highlights

• Significant changes to financial reporting effective January 1, 2026: The company will no longer report “service line fee revenue” and several non-GAAP measures, including Adjusted EBITDA margin, Segment operating expenses, and Fee-based operating expenses.
• Revised definition and presentation of “Cost of gross contract reimbursables”: These are now reported as “Gross contract costs” and include reimbursed client-dedicated labor, subcontractor costs, and third-party consumables, with comparative periods recast to conform with the new definition.
• Enhanced allocation of corporate costs among segments: This has affected previously reported Net income (loss) and Adjusted EBITDA by segment but has no impact on consolidated results.
• No impact on total revenue, consolidated net income (loss), or cash flows for prior periods: The changes are purely presentational and do not alter the company’s underlying financial performance.
• Adjusted EBITDA remains a key performance measure: The company continues to report Adjusted EBITDA, which eliminates certain non-operating and one-time items to improve comparability and transparency.
• Detailed unaudited recast historical financials for 2024 and 2025 provided: Full segment breakdowns and reconciliations have been released for investor analysis.

Detailed Reporting Changes

Cushman & Wakefield Ltd. has implemented sweeping changes to its financial reporting, aimed at aligning with industry competitors and enhancing the clarity of its financial statements for both management and investors. Notably, from January 1, 2026, the company will stop reporting several non-GAAP financial measures and will present “Gross contract costs” as a separate line item in total costs and expenses. This line now includes all reimbursed costs, such as client-dedicated labor, subcontractor expenses, and consumables that are specific to cost-based client contracts.

Historical financials for 2024 and 2025 have been recast to reflect these changes, providing investors with a consistent basis for comparison. The company emphasized that these presentational changes do not affect total revenue, consolidated net income or cash flows in any previously reported periods, but do impact segment-level results due to a refined allocation of corporate costs.

Implications for Shareholders

• Potential Impact on Share Price: The move to align reporting with competitors, provide greater transparency, and eliminate certain non-GAAP measures could be viewed positively by the market, as it enhances comparability and clarity for investors. However, the elimination of certain metrics may also reduce some granularity for those who relied on those non-GAAP measures.
• Recast Segment Profitability: The refined allocation of corporate costs may result in changes to previously reported segment profitability, which could influence perceptions of the performance of individual business lines.
• No Impact on Fundamental Financials: Investors should note that the underlying financial health of the company remains unchanged, as there is no impact on consolidated revenue, earnings, or cash flows.
• Detailed Adjusted EBITDA Reconciliation: The company continues to provide Adjusted EBITDA at the consolidated and segment level, excluding the effects of items such as unrealized investment gains/losses, impairment charges, acquisition costs, and one-time system implementation costs. This measure is intended to provide a more accurate view of ongoing operating performance.

Full Recast Financials: 2024 and 2025 (Selected Data)

Consolidated Results (Unaudited, \$ in millions):

• 2024 Total Revenue: \$9,446.5M
• 2024 Operating Income: \$338.9M
• 2024 Net Income: \$131.3M
• 2024 Adjusted EBITDA: \$581.9M
• 2025 Total Revenue: \$10,288.2M
• 2025 Operating Income: \$452.5M
• 2025 Net Income: \$88.2M
• 2025 Adjusted EBITDA: \$656.2M
• Gross contract costs (reimbursed client costs): \$3,787.1M (2024), \$4,239.7M (2025)

Segment Results:

• Americas Adjusted EBITDA: \$427.9M (2024), \$473.5M (2025)
• EMEA Adjusted EBITDA: \$81.1M (2024), \$107.3M (2025)
• APAC Adjusted EBITDA: \$72.9M (2024), \$75.4M (2025)

Note: The company provides detailed quarterly breakdowns and reconciliations for all metrics.

What Investors Should Watch

• The cessation of several non-GAAP metrics may lead to a transition period for analysts and investors accustomed to those figures. Management’s intent is to simplify reporting and focus on metrics that provide a clearer view of business performance.
• The recast of historical segment results may prompt market participants to re-evaluate the relative performance and prospects of the company’s operating segments.
• The company’s improved transparency and alignment with industry standards may support a re-rating of shares, depending on investor perception.

Conclusion

The reporting changes announced by Cushman & Wakefield Ltd. are significant and could influence how the company is valued by the market. While there is no impact on underlying financial performance, the enhanced comparability, transparency, and focus on core financial measures are likely to be welcomed by shareholders seeking clarity. Investors are encouraged to review the recast segment information and new presentation of results to understand the company’s ongoing performance.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with a financial advisor before making any investment decisions. The information provided is based on unaudited financial data and is subject to change.

View Cushman & Wakefield Ltd. Historical chart here